Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by NorthStarron Jun 15, 2010 10:38am
397 Views
Post# 17189618

RE: Something wierd on TD

RE: Something wierd on TDLMAO Loki .... were the little ones keeping you up to late and your waking up all tired or did you not have enough coffee before you were looking at SSS's EPS?

You read 0.05 correct but you missed the minus symbol before it !!!

  • EPS -0.05

I also did some looking for the insider sale and came up empty handed. They have 5 days or something to report so it might be a day or two to soon for it to show up. ( https://www.sedi.com )

Get this, from the The Globe this morning.....

( View it here https://www.theglobeandmail.com/globe-investor/markets/stocks/analyst-ratings/?q=SSS-X )

As of Tue Jun 15, 2010 10:31 AM EDT
SSS - "Strong Buy"
Theconsensus recommendation is the average buy, sell or hold rating for acompany, based on a survey of brokerage equity analysts by Zacks Investment Research. We update theratings daily.

hmmm what does their analyst know ???


Nort
Bullboard Posts